90 related articles for article (PubMed ID: 22818167)
21. CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.
Bisig B; de Reyniès A; Bonnet C; Sujobert P; Rickman DS; Marafioti T; Delsol G; Lamant L; Gaulard P; de Leval L
Haematologica; 2013 Aug; 98(8):1250-8. PubMed ID: 23716562
[TBL] [Abstract][Full Text] [Related]
22. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
23. Accumulation of BCL10 at the perinuclear region is required for the BCL10-mediated nuclear factor-kappa B activation.
Nakamura K; Senda T; Sato K; Mori S; Moriyama M
Pathobiology; 2005; 72(4):191-202. PubMed ID: 16127295
[TBL] [Abstract][Full Text] [Related]
24. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
Marafioti T; Paterson JC; Ballabio E; Chott A; Natkunam Y; Rodriguez-Justo M; Plonquet A; Rodriguez-Pinilla SM; Klapper W; Hansmann ML; Pileri SA; Isaacson PG; Stein H; Piris MA; Mason DY; Gaulard P
Haematologica; 2010 Mar; 95(3):432-9. PubMed ID: 20207847
[TBL] [Abstract][Full Text] [Related]
25. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.
Lobry C; Lopez T; Israël A; Weil R
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):908-13. PubMed ID: 17213322
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma.
Konstantinou K; Yamamoto K; Ishibashi F; Mizoguchi Y; Kurata M; Nakagawa Y; Suzuki K; Sawabe M; Ohta M; Miyakoshi S; Crawley JT; Kitagawa M
Br J Haematol; 2009 Mar; 144(5):696-704. PubMed ID: 19120365
[TBL] [Abstract][Full Text] [Related]
27. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
28. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
[TBL] [Abstract][Full Text] [Related]
29. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
[TBL] [Abstract][Full Text] [Related]
30. Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome.
Briones J; Moga E; Espinosa I; Vergara C; Alvarez E; Villa J; Bordes R; Delgado J; Prat J; Sierra J
Histopathology; 2009 Mar; 54(4):478-85. PubMed ID: 19309400
[TBL] [Abstract][Full Text] [Related]
31. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
32. HOXC4, HOXC5, and HOXC6 expression in primary cutaneous lymphoid lesions. High expression of HOXC5 in anaplastic large-cell lymphomas.
Bijl JJ; Rieger E; van Oostveen JW; Walboomers JM; Kreike M; Willemze R; Meijer CJ
Am J Pathol; 1997 Oct; 151(4):1067-74. PubMed ID: 9327740
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.
Courts C; Montesinos-Rongen M; Martin-Subero JI; Brunn A; Siemer D; Zühlke-Jenisch R; Pels H; Jürgens A; Schlegel U; Schmidt-Wolf IG; Schaller C; Reifenberger G; Sabel M; Warnecke-Eberz U; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2007 Mar; 66(3):230-7. PubMed ID: 17356384
[TBL] [Abstract][Full Text] [Related]
34. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
36. Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations.
Costello R; Sanchez C; Le Treut T; Rihet P; Imbert J; Sébahoun G
Br J Haematol; 2010 Jul; 150(1):21-7. PubMed ID: 19912218
[TBL] [Abstract][Full Text] [Related]
37. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas.
Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
[TBL] [Abstract][Full Text] [Related]
38. Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.
Agostinelli C; Rizvi H; Paterson J; Shende V; Akarca AU; Agostini E; Fuligni F; Righi S; Spagnolo S; Piccaluga PP; Clark EA; Pileri SA; Marafioti T
Am J Surg Pathol; 2014 Oct; 38(10):1349-59. PubMed ID: 25118816
[TBL] [Abstract][Full Text] [Related]
39. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
40. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.
Copie-Bergman C; Plonquet A; Alonso MA; Boulland ML; Marquet J; Divine M; Möller P; Leroy K; Gaulard P
Mod Pathol; 2002 Nov; 15(11):1172-80. PubMed ID: 12429796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
